Package 68788-7786-1

{"route": ["ORAL"], "spl_id": "35ff52b6-09b7-4f6f-9248-5e49690212b3", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["42e228a2-25b3-44a6-8da7-6616ca44ac7f"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-1)", "package_ndc": "68788-7786-1", "marketing_start_date": "20201021"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-3)", "package_ndc": "68788-7786-3", "marketing_start_date": "20201021"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-6)", "package_ndc": "68788-7786-6", "marketing_start_date": "20201021"}, {"sample": false, "description": "120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-8)", "package_ndc": "68788-7786-8", "marketing_start_date": "20201021"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-9)", "package_ndc": "68788-7786-9", "marketing_start_date": "20201021"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "68788-7786_35ff52b6-09b7-4f6f-9248-5e49690212b3", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "68788-7786", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA210497", "marketing_category": "ANDA", "marketing_start_date": "20201021", "listing_expiration_date": "20261231"}